1. Abeloff MD,Waterbury L (1974) Pure red blood cell aplasia and chronic lymphocytic leukemia. Arch Intern Med 134: 721–724
2. Axdorph U, Nilsson BI, Nilsson BR,Bjorkholm M (1995) Leucocyte doubling time is a useful predictor of progression-free survival in chronic lymphocytic leukemia.J Intern Med 237: 205–209
3. Barlett NL, Longo DL (1999) T-small lymphocyte disorders.Semin Hematol 36: 164–170
4. Bastion Y, Coiffier B, Dumontet C, Espinouse D, Bryon PA (1992) Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Ann Oncol 3: 171–172
5. Bennett JM, Raphael B, Moore D, Silber R, Oken MM, Rubin P (1987) Cornparison of chlorambucil and prednisone vs total body irradiation and chlorambucil: prednisone vs cytoxan, vincristine, prednisone for the therapy of active chronic lymphocytic leukemia:a long term follow-up of two ECOG studies. In: Gale P, Rai KR (eds) Chronic lymphocytic leukemia: recent progress and future directions. Liss, New York, pp 317–327